Cell MedX Corp. | Balance Sheet

Fiscal year is June-May. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
11.00
1.20
1.30
27.60
67.50
8.20
Inventories
-
-
0.70
4.60
8.20
10.80
Other Current Assets
-
-
18.80
29.70
24.50
26.30
Total Current Assets
11.00
1.20
20.70
61.80
100.20
45.30
Net Property, Plant & Equipment
-
-
25.80
207.10
193.60
-
Total Assets
11.00
1.20
46.60
268.90
293.70
45.30
ST Debt & Current Portion LT Debt
-
-
10.00
907.60
528.60
Accounts Payable
-
1.90
220.00
384.10
447.60
Other Current Liabilities
12.80
19.60
500.60
389.70
486.90
Total Current Liabilities
12.80
21.60
730.60
1,681.50
1,463.10
Total Liabilities
12.80
21.60
730.60
1,681.50
1,463.10
Common Equity (Total)
1.90
20.40
684.10
1,412.60
1,169.30
Total Shareholders' Equity
1.90
20.40
684.10
1,412.60
1,169.30
Total Equity
1.90
20.40
684.10
1,412.60
1,169.30
Liabilities & Shareholders' Equity
11.00
1.20
46.60
268.90
293.70

About Cell MedX

View Profile
Address
123 West Nye Lane
Carson City Nevada 89706
United States
Employees -
Website http://www.cellmedx.com
Updated 07/08/2019
Cell MedX Corp. is a development stage company. It engages in providing technology for the treatment of diabetes and related ailments. The company was founded by Mario Santos Gregorio and Rizalina Raneses on March 19, 2010 and is headquartered in Carson City, NV.